These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 21905786

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bacteriophages as potential new therapeutics to replace or supplement antibiotics.
    Kutateladze M, Adamia R.
    Trends Biotechnol; 2010 Dec; 28(12):591-5. PubMed ID: 20810181
    [Abstract] [Full Text] [Related]

  • 3. Preventing biofilms of clinically relevant organisms using bacteriophage.
    Donlan RM.
    Trends Microbiol; 2009 Feb; 17(2):66-72. PubMed ID: 19162482
    [Abstract] [Full Text] [Related]

  • 4. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM, Ritter K, Horz HP.
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [Abstract] [Full Text] [Related]

  • 5. Bacteriophage therapy in children: facts and prospects.
    Fortuna W, Miedzybrodzki R, Weber-Dabrowska B, Górski A.
    Med Sci Monit; 2008 Aug; 14(8):RA126-32. PubMed ID: 18668009
    [Abstract] [Full Text] [Related]

  • 6. The perspectives of the application of phage therapy in chronic bacterial prostatitis.
    Letkiewicz S, Międzybrodzki R, Kłak M, Jończyk E, Weber-Dąbrowska B, Górski A.
    FEMS Immunol Med Microbiol; 2010 Nov; 60(2):99-112. PubMed ID: 20698884
    [Abstract] [Full Text] [Related]

  • 7. Treatment of post-burns bacterial infections by bacteriophages, specifically ubiquitous Pseudomonas spp. notoriously resistant to antibiotics.
    Ahmad SI.
    Med Hypotheses; 2002 Apr; 58(4):327-31. PubMed ID: 12027527
    [Abstract] [Full Text] [Related]

  • 8. Phage therapy: facts and fiction.
    Skurnik M, Strauch E.
    Int J Med Microbiol; 2006 Feb; 296(1):5-14. PubMed ID: 16423684
    [Abstract] [Full Text] [Related]

  • 9. Review: phage therapy: a modern tool to control bacterial infections.
    Qadir MI.
    Pak J Pharm Sci; 2015 Jan; 28(1):265-70. PubMed ID: 25553704
    [Abstract] [Full Text] [Related]

  • 10. Phage therapy: past history and future prospects.
    Carlton RM.
    Arch Immunol Ther Exp (Warsz); 1999 Jan; 47(5):267-74. PubMed ID: 10604231
    [Abstract] [Full Text] [Related]

  • 11. [Bacteriophages as antibacterial agents].
    Shasha SM, Sharon N, Inbar M.
    Harefuah; 2004 Feb; 143(2):121-5, 166. PubMed ID: 15143702
    [Abstract] [Full Text] [Related]

  • 12. Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far.
    Łusiak-Szelachowska M, Międzybrodzki R, Drulis-Kawa Z, Cater K, Knežević P, Winogradow C, Amaro K, Jończyk-Matysiak E, Weber-Dąbrowska B, Rękas J, Górski A.
    J Biomed Sci; 2022 Mar 30; 29(1):23. PubMed ID: 35354477
    [Abstract] [Full Text] [Related]

  • 13. Bacteriophage therapy: a potential solution for the antibiotic resistance crisis.
    Golkar Z, Bagasra O, Pace DG.
    J Infect Dev Ctries; 2014 Feb 13; 8(2):129-36. PubMed ID: 24518621
    [Abstract] [Full Text] [Related]

  • 14. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE, Rybak MJ.
    Pharmacotherapy; 2006 Aug 13; 26(8):1099-110. PubMed ID: 16863487
    [Abstract] [Full Text] [Related]

  • 15. The next generation of bacteriophage therapy.
    Lu TK, Koeris MS.
    Curr Opin Microbiol; 2011 Oct 13; 14(5):524-31. PubMed ID: 21868281
    [Abstract] [Full Text] [Related]

  • 16. Phage therapy: a reappraisal of bacteriophages as antibiotics.
    Inal JM.
    Arch Immunol Ther Exp (Warsz); 2003 Oct 13; 51(4):237-44. PubMed ID: 12956433
    [Abstract] [Full Text] [Related]

  • 17. Phage therapy--history from Twort and d'Herelle through Soviet experience to current approaches.
    Chanishvili N.
    Adv Virus Res; 2012 Oct 13; 83():3-40. PubMed ID: 22748807
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bacteriophages as anti-infective agents: recent developments and regulatory challenges.
    Gilmore BF.
    Expert Rev Anti Infect Ther; 2012 May 13; 10(5):533-5. PubMed ID: 22702317
    [Abstract] [Full Text] [Related]

  • 20. Big Impact of the Tiny: Bacteriophage-Bacteria Interactions in Biofilms.
    Hansen MF, Svenningsen SL, Røder HL, Middelboe M, Burmølle M.
    Trends Microbiol; 2019 Sep 13; 27(9):739-752. PubMed ID: 31128928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.